Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.

Spyre Therapeutics

Wasserman is a diversified investment firm with a focus on creating value through strategic investments in various sectors.

Wasserman

Xponential Fitness is an investment firm with a strong emphasis on the fitness and wellness sector, aiming to create value through innovative investments.

Xponential Fitness

Adpen Pty Ltd is an investment firm involved in real estate and property development, focusing on creating value through strategic investments in the real estate sector.

Adpen Pty Ltd

Nireeda Homes is a real estate investment firm specializing in property development and investment in the real estate sector.

Nireeda Homes

CFMG Capital Ltd is an investment firm that focuses on creating value through strategic investments in the real estate sector, particularly in property development and management.

CFMG Capital Ltd

Spyre Group is a diversified investment firm that focuses on creating value by investing in and developing a wide range of assets. The company operates across various sectors, including real estate, technology, and consumer services, with a strong emphasis on innovation and strategic growth.

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Spyre Therapeutics, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 8:30 AM	653cf382
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 14, 2024 8:30 AM	2179fd54
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

SYRE

COM:SPYRE

Spyre Group

Last Close

27.00

22/11 21:00

Market Cap

1.42B

Beta: -

Volume Today

781.50K

Avg: -